Barrister, peer and Vice-President of the Patients Association Baroness Helena Kennedy has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7424051-helena-kennedy-astellas-debate/
George Freeman MP, the Minister for Life Sciences, will give the keynote address at the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
Organised and funded by Astellas, a progressive pharmaceutical company that explores the frontiers of scientific discovery to translate new knowledge into innovative, reliable medicines, the Astellas Innovation Debates are a series of annual events that bring together some of the world’s most progressive thinkers to discuss the role of innovation in solving some of the greatest challenges of our time.
George Freeman’s keynote address will outline the Government’s aim to develop, assess and adopt new drugs, devices and diagnostics as we move towards 21st century, personalised healthcare.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7423951-george-freeman-astellas-debate/
Professor Lionel Tarassenko, CBE, Head of Engineering at the University of Oxford and Fellow of the Royal Academy of Engineering and the Academy of Medical Sciences, has joined a panel of internationally recognised experts for the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
As the worlds of science and technology come together, the 2015 Astellas Innovation Debate, organised and funded by Astellas, will discuss recent breakthroughs in genetic medicine and smart technology, and what they mean for our health.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7432051-lionel-tarassenko-astellas-debate/
The Mohammed bin Rashid Al Maktoum Global Initiatives and the Bill & Melinda Gates Foundation today launched a global thought leadership platform to help frame and stimulate regional and global debate on vital development issues shaping the Middle East.
The “Middle East Exchange” will commission original articles from international experts including Nobel laureates, heads of state, academics and intellectuals. New articles will be published weekly in newspapers globally on a wide range of topics relevant to the region, from health and education to development and innovation.
UAE Minister of Cabinet Affairs His Excellency Mohammed Al Gergawi discussed the project at a meeting with Bill Gates, Co-Chair of the Bill & Melinda Gates Foundation, in Abu Dhabi on December 6. Speaking after the meeting, H.E. Al Gergawi said:
“The Middle East has spent too long in the global spotlight as a source of conflict and trouble. His Highness Sheikh Mohammed bin Rashid’s vision is for innovative and tangible solutions that benefit people’s lives on the ground. There is a huge appetite for practical ideas. The Middle East Exchange will be the number one global platform for positive voices and ideas for the Middle East.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7719851-mohammed-al-maktoum-global-initiatives/
Personalised Medicine is the future of cancer treatment, but it presents major challenges for doctors and health services, the President of the European Society of Medical Oncology has said. Professor Rolf Stahel was speaking ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430351-professor-rolf-stahel-astellas-debate/
Advanced technology has the power to transform healthcare, a world leader in the field of genomicsDr Leroy Hood, has said ahead of the 3rd Astellas Innovation Debate: i-Genes – What the DNA and Data Revolutions mean for our Health, taking place on Thursday 29th January 2015 at the Royal Institution of Great Britain.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7430051-dr-leroy-hood-astellas-debate/
There is a lot of controversy and debate about whether you need to do a colon cleansing. Some say it is necessary and others say it's a waste of money and can do your body harm. You can imagine who it says it harms. Doctors say it's a waste of time and practitioners that offer a colon cleansing service cleansing say it is not. So who will you believe?
The Government’s draft Deregulation Bill first appeared in June last year. Clause 1 of that draft bill includes proposals to exempt certain self-employed people from health and safety law. This has caused some controversy among health and safety professionals, who believe that the exemption could lead to confusion, increasing the risk of injury, illness and death as a result.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400542-SHP-IOSH-deregulation-bill
On the eve of World Cancer Day 2015, amidst the ongoing cost-of-cancer-care debate, PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative, is launching the PACE Continuous Innovation Indicators™ (CII). CII is the first evidence-based, customizable online tool to review progress against cancer over time—initially covering 12 cancer types. The purpose of the tool is to inform public policy reforms and other efforts to accelerate continuous innovation against cancer.
“We have seen tremendous progress in cancer treatment and care during the past decades, and continuous innovation, with one discovery building on another, is responsible for most of it,” said John C. Lechleiter, Ph.D., Chairman, President, and Chief Executive Officer of Eli Lilly and Company (NYSE:LLY). “To keep the momentum going, we need policies that support continuous innovation, but first we need a deeper understanding of the innovations that have occurred, and where we need to be.”
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7419451-eli-lilly-oncology-pace/
Construction is complete at A/D/O, a new 23,000 square-foot creative space, which opens to the public in Greenpoint, Brooklyn following the holiday season. At the core of A/D/O is its Design Academy, which aims to inspire pioneering work and be a forum for interdisciplinary debate. A/D/O will provide unique opportunities for professional development while inviting the broader public to explore design through a range of installations, exhibitions and events.
The Design Academy at A/D/O will offer an ambitious seasonal program geared towards design professionals, which stimulates relevant dialogue and new work through talks and workshops, special exhibitions and commissions and designer residencies. Its first program, entitled “Utopia vs. Dystopia: Designing Our Imagined Futures,” investigates the role design plays in a world of rapid change. Partnerships with design firms MOS Architects, OLIN, Stephen Burks Man Made and Turner-prize winning collective Assemble, as well as talks from Yves Behar and Alice Rawsthorn among others, are important components of this inaugural season, which will kick off with a three-day festival January 27-29, 2017.
To view the multimedia release go to:
http://www.multivu.com/players/English/7978851-a-d-o-opens-design-academy-greenpoint-brooklyn/
